Leukemia & lymphoma/Leukemia and lymphoma · 1998 · 30 citations · 7 references
MedicineHematologyPathologyHematopathologyHistopathologyNeoplasiaHematologic MalignanciesHistiocytic DisordersMalignant NeoplasmsMalignant TumorsSplenic PathologyTumor HistopathologyClinical SymptomsHistiocytic SarcomaHistologic Tumor ClassificationHistopathological Tumor ClassificationSpleen HistologySpleen HistopathologySplenic HistologySplenic Metastasis
We report three patients with histiocytic sarcoma of the spleen associated with severe hypoalbuminemia, hypo gamma-globulinemia and thrombocytopenia. After the clinical diagnosis of splenic tumor of unknown origin was made, all three patients underwent splenectomy. The histiocytic origin of the tumor was confirmed histopathologically and immunohistochemically using a panel of antibodies. In contrast to malignant histiocytosis (MH), which typically reveals severe generalized clinical manifestations and a rapidly fatal course caused by the disseminated proliferation of neoplastic histiocytes, these patients were asymptomatic or showed only mild clinical symptoms for a long period of time until the recurrence was detected by which time the tumor cells had already spread to other organs. All three cases were characteristically associated with hypoalbuminemia, hypo gamma-globulinemia and thrombocytopenia, which returned to normal after splenectomy. Splenic histiocytic sarcoma with the features described here may represent a unique clinical entity, distinct from MH.
7
S M Hsu, Laurence Raine, Herbert Fanger · Journal of Histochemistry & Cytochemistry · 1981 · 14.3K citations · Full text
Mac 387 antibody and detection of formalin resistant myelomonocytic L1 antigen.
P Brandtzæg, David B. Jones, David J. Flavell et al. · Journal of Clinical Pathology · 1988 · 116 citations · Full text
Pharmacy, Immunology, Pathology +14
The treatment of malignant histiocytosis
A Jr Tseng, CN Coleman, R S Cox et al. · Blood · 1984 · 36 citations · Full text